Steroidogenic factor-1 (SF-1, NR5A1) and human disease
暂无分享,去创建一个
[1] J. Jameson,et al. A Naturally Occurring Steroidogenic Factor-1 Mutation Exhibits Differential Binding and Activation of Target Genes* , 2000, The Journal of Biological Chemistry.
[2] K. Parker,et al. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. , 1992, Molecular endocrinology.
[3] D. Douguet,et al. Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists. , 2009, The Journal of clinical endocrinology and metabolism.
[4] E. Lalli,et al. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. , 2007, Molecular endocrinology.
[5] Y. Morel,et al. Gonadal dysgenesis without adrenal insufficiency in a 46, XY patient heterozygous for the nonsense C16X mutation: a case of SF1 haploinsufficiency. , 2004, The Journal of clinical endocrinology and metabolism.
[6] J. Jameson,et al. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience. , 2006, The Journal of clinical endocrinology and metabolism.
[7] M. Polak,et al. Steroidogenic factor-1 (SF-1) gene mutation as a frequent cause of primary amenorrhea in 46,XY female adolescents with low testosterone concentration , 2010, Reproductive biology and endocrinology : RB&E.
[8] J. Tremblay,et al. A Mutated Form of Steroidogenic Factor 1 (SF-1 G35E) That Causes Sex Reversal in Humans Fails to Synergize with Transcription Factor GATA-4* , 2003, Journal of Biological Chemistry.
[9] N. Sebire,et al. Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1. , 2010, American journal of human genetics.
[10] B. Schimmer,et al. Steroidogenic factor 1: a key determinant of endocrine development and function. , 1997, Endocrine reviews.
[11] P. Hindmarsh,et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans , 1999, Nature Genetics.
[12] E. Lalli,et al. Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. , 2005, The Journal of clinical endocrinology and metabolism.
[13] H. Ingraham,et al. Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function. , 2004, Molecular endocrinology.
[14] Serdar E Bulun,et al. Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5' CpG island in endometriosis. , 2007, The Journal of clinical endocrinology and metabolism.
[15] M. Nagano,et al. Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz‐F1 disrupted mice , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.
[16] S. Bornstein,et al. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] T. Ogata,et al. Association of severe micropenis with Gly146Ala polymorphism in the gene for steroidogenic factor-1. , 2005, Endocrine journal.
[18] A. Belgorosky,et al. Three New SF-1 (NR5A1) Gene Mutations in Two Unrelated Families with Multiple Affected Members: Within-Family Variability in 46,XY Subjects and Low Ovarian Reserve in Fertile 46,XX Subjects , 2010, Hormone Research in Paediatrics.
[19] A. Latronico,et al. Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. , 2010, The Journal of clinical endocrinology and metabolism.
[20] J. Milbrandt,et al. Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Rossi,et al. The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency , 2009, European journal of endocrinology.
[22] S. Bulun,et al. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. , 2009, Cancer research.
[23] J. McGarry,et al. Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. , 2002, Endocrinology.
[24] D. Tellería,et al. Screening for mutations in the steroidogenic acute regulatory protein and steroidogenic factor-1 genes, and in CYP11A and dosage-sensitive sex reversal-adrenal hypoplasia gene on the X chromosome, gene-1 (DAX-1), in hyperandrogenic hirsute women. , 2001, The Journal of clinical endocrinology and metabolism.
[25] F. Beuschlein,et al. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. , 2010, The Journal of clinical endocrinology and metabolism.
[26] T. Ogata,et al. Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1. , 2004, The Journal of clinical endocrinology and metabolism.
[27] P. Philibert,et al. Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. , 2007, Human reproduction.
[28] Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease. , 2010, Molecular endocrinology.
[29] W. Rainey,et al. A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. , 2004, The Journal of clinical endocrinology and metabolism.
[30] A. Grüters,et al. Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency , 2008, Human mutation.
[31] C. V. van Ravenswaaij-Arts,et al. A unique 970kb microdeletion in 9q33.3, including the NR5A1 gene in a 46,XY female. , 2009, European journal of medical genetics.
[32] K. McElreavey,et al. Mutations in NR5A1 associated with ovarian insufficiency. , 2009, The New England journal of medicine.
[33] K. Umesono,et al. Determinants of target gene specificity for steroid/thyroid hormone receptors , 1989, Cell.
[34] K. Fujieda,et al. A novel heterozygous mutation of steroidogenic factor-1 (SF-1/Ad4BP) gene (NR5A1) in a 46, XY disorders of sex development (DSD) patient without adrenal failure. , 2009, Endocrine journal.
[35] B. Köhler,et al. Update--steroidogenic factor 1 (SF-1, NR5A1). , 2010, Minerva endocrinologica.
[36] Takashi Suzuki,et al. Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis. , 2008, Molecular endocrinology.
[37] M. Matsuo,et al. A novel mutation in the accessory DNA-binding domain of human steroidogenic factor 1 causes XY gonadal dysgenesis without adrenal insufficiency. , 2007, European journal of endocrinology.
[38] H. Handa,et al. A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. , 1992, The Journal of biological chemistry.
[39] K. Parker,et al. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation , 1994, Cell.
[40] T. Ogata,et al. Association of cryptorchidism with Gly146Ala polymorphism in the gene for steroidogenic factor-1. , 2006, Fertility and sterility.
[41] E. Schoenle,et al. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. , 2000, American journal of human genetics.
[42] J. Jameson,et al. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. , 2002, The Journal of clinical endocrinology and metabolism.
[43] Laurie D. Smith,et al. Ovotestes and XY sex reversal in a female with an interstitial 9q33.3‐q34.1 deletion encompassing NR5A1 and LMX1B causing features of genitopatellar syndrome , 2007, American journal of medical genetics. Part A.
[44] Y. Morel,et al. Heterozygous mutation of steroidogenic factor-1 in 46,XY subjects may mimic partial androgen insensitivity syndrome. , 2007, The Journal of clinical endocrinology and metabolism.
[45] M. Dattani,et al. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. , 2007, The Journal of clinical endocrinology and metabolism.
[46] A. Lewis,et al. Molecular aspects of steroidogenic factor 1 (SF-1) , 2010, Molecular and Cellular Endocrinology.
[47] K. Parker,et al. A shared promoter element regulates the expression of three steroidogenic enzymes. , 1991, Molecular endocrinology.
[48] J. Achermann,et al. Steroidogenic Factor-1 (SF-1, Ad4BP, NR5A1) and Disorders of Testis Development , 2008, Sexual Development.